Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Beta Bionics, Inc.NASDAQ: BBNX
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI turns negative
Q1 FY2026 Accumulated OCI was -$96K, compared with $240K a year earlier.
Context
- Accumulated OCI amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Accumulated OCI increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -140.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 403K USD
- Year-over-year change
- +520.0%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 403K | +520.0% |
| FY2024 | 2024-12-31 | 65K | -52.6% |
| FY2023 | 2023-12-31 | 137K | — |
| FY2022 | 2022-12-31 | 0 | — |
Accumulated OCI vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -140.0% is the 5th highest of 6, against a peer median of -88.3%.
- Accumulated OCI amounts to 0.0% of total assets for BBNX, versus a peer median of 0.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $90M USD | +7.7% | — | 1.4% | |
| Mar 2026 | $5.04M USD | +6625.3% | — | 0.4% | |
| Jun 2026 | $1.9M USD | -88.3% | -12.9% | 0.1% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | -$4K USD | -100.3% | — | 0.0% | |
| Mar 2026 | -$96K USD | -140.0% | — | 0.0% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | -$14M USD | — | — | 0.3% |
| Jun 2026 | -DKK 3.33B DKK | -205.0% | — | 0.6% | |
| Peer median (excluding BBNX) | — | -88.3% | -12.9% | 0.3% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.